Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation
/in Chronic Leukemia, International Publications /von 2006-03-09 / Leuk. Res. 2006 Jul;30(7):785-94Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma
/in International Publications, Malignant Lymphoma /von 2006-03-07 / Ann. Hematol. 2006 May;85(5):308-14Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice
/in Dendritic Cells, Hyperthermia, International Publications /von 2006-03-03 / Biochem. Biophys. Res. Commun. 2006 Apr;343(1):269-78Combined action of virus injection and local tumor irradiation on tumor growth in mice
/in International Publications, Newcastle Disease Virus /von 2006-03-01 / Coll Antropol 2006 Mar;30(1):185-9Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses
/in International Publications, Malignant Melanoma /von 2006-03-01 / Int. J. Oncol. 2006 Mar;28(3):585-93
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution